Loading organization details...
Loading organization details...
Source: IRS e-Filed Form 990 (from the IRS e-File system), Tax Year 2023
Total Revenue
▼$46.2K
Program Spending
0%
of total expenses go to program services
Total Contributions
$0
Total Expenses
▼$60K
Total Assets
$1M
Total Liabilities
▼$0
Net Assets
$1M
Officer Compensation
→N/A
Other Salaries
N/A
Investment Income
$46.1K
Fundraising
▼N/A
Source: USAspending.gov · Searched by organization name
VA/DoD Awards
$5.9M
VA/DoD Award Count
1
Funding from the Department of Veterans Affairs and/or Department of Defense.
Total Federal Funding
$22.4M
Awards Found
10
| Awarding Agency | Description | Amount | Fiscal Year | Period |
|---|---|---|---|---|
| Department of Health and Human Services | NEW APPROACHES TO TISSUE REPAIR | $9.5M | FY2003 | Sep 2003 – Apr 2013 |
| VA/DoDDepartment of Defense | T-CELL GENE THERAPY TO ERADICATE DISSEMINATED BREAST CANCERS | $5.9M | FY2009 | May 2009 – Oct 2014 |
| Department of Health and Human Services | NEW APPROACHES TO TISSUE REPAIR | $2.3M | FY2003 | Sep 2003 – Apr 2013 |
| Department of Health and Human Services | P38 ACETYLATION: NOVEL SIGNALING MECHANISMS AND MYOCARDIAL PROTECTION | $1.6M | FY2013 | Jul 2013 – Apr 2017 |
| Department of Health and Human Services | A BIOENGINEERING APPROACH TO CREATE IMMUNOREJECTION FREE HUMAN PANCREATIC ISLETS | $1.2M | FY2013 | Jul 2013 – Jun 2017 |
| Department of Health and Human Services | REVERSING GENETICALLY MODIFIED T CELL SUPPRESSION IN A MODEL OF LIVER METASTASES | $838.2K | FY2012 | Apr 2012 – Mar 2017 |
| Department of Health and Human Services | ANTI-CEA DESIGNER T CELLS IN GASTRIC CANCER, PHASE I TR* | $437.5K | FY2006 | Feb 2006 – Jan 2010 |
| Department of Health and Human Services | EGFRBI-ARMED ATC FOR ADVANCED NSCLC: A PHASE I TRIAL | $378.9K | FY2007 | Sep 2007 – Dec 2014 |
| Department of Health and Human Services | REPLICATION POTENTIAL AND CELL-TROPISM OF RESIDUAL PLASMA HIVS | $171K | FY2012 | May 2012 – Apr 2015 |
| Department of Health and Human Services | IN-VITRO MODEL TO RECAPITULATE THE NATURAL HIV-1 LATENCY | $110K | FY2015 | Jun 2015 – Sep 2017 |
Department of Health and Human Services
$9.5M
NEW APPROACHES TO TISSUE REPAIR
Department of Defense
$5.9M
T-CELL GENE THERAPY TO ERADICATE DISSEMINATED BREAST CANCERS
Department of Health and Human Services
$2.3M
NEW APPROACHES TO TISSUE REPAIR
Department of Health and Human Services
$1.6M
P38 ACETYLATION: NOVEL SIGNALING MECHANISMS AND MYOCARDIAL PROTECTION
Department of Health and Human Services
$1.2M
A BIOENGINEERING APPROACH TO CREATE IMMUNOREJECTION FREE HUMAN PANCREATIC ISLETS
Department of Health and Human Services
$838.2K
REVERSING GENETICALLY MODIFIED T CELL SUPPRESSION IN A MODEL OF LIVER METASTASES
Department of Health and Human Services
$437.5K
ANTI-CEA DESIGNER T CELLS IN GASTRIC CANCER, PHASE I TR*
Department of Health and Human Services
$378.9K
EGFRBI-ARMED ATC FOR ADVANCED NSCLC: A PHASE I TRIAL
Department of Health and Human Services
$171K
REPLICATION POTENTIAL AND CELL-TROPISM OF RESIDUAL PLASMA HIVS
Department of Health and Human Services
$110K
IN-VITRO MODEL TO RECAPITULATE THE NATURAL HIV-1 LATENCY
Source: Federal Audit Clearinghouse (fac.gov)
No federal single audit records found for this organization.
Single audits are required for entities expending $750,000+ in federal awards annually.
Tax Year 2024 · Source: IRS e-Filed Form 990
Individuals serving as officers, directors, or trustees of the organization.
| Name | Title | Hrs/Wk | Compensation | Related Orgs | Other |
|---|
Source: IRS Publication 78, Auto-Revocation List & e-Postcard Data
Tax-deductible contributions: Yes
Deductibility code: PC
Sources: IRS e-Filed Form 990 (XML) & ProPublica Nonprofit Explorer
Scroll →
| Year | Revenue | Contributions | Expenses | Assets | Net Assets |
|---|---|---|---|---|---|
| 2023IRS e-File | $46.2K | $0 | $60K | $1M | $1M |
| 2022 | $227.6K | $0 | $530.4K | $1M | $1M |
| 2021 | $4.1M | $100K | $198.8K | $1.3M | $1.3M |
| 2020 | $208.2K | $0 | $10.1M |
Sources: ProPublica Nonprofit Explorer & IRS e-File Index
| Tax Year | Form Type | Source | Documents |
|---|---|---|---|
| 2024 | 990 | IRS e-File | PDF not yet published by IRSView Filing → |
| 2023 | 990 | DataIRS e-File | |
| 2022 | 990 | DataIRS e-File |
Financial data: IRS e-Filed Form 990 (Tax Year 2023)
Leadership & compensation: IRS e-Filed Form 990, Part VII (Tax Year 2024)
Federal grants: USAspending.gov (live)
Organization info: IRS Business Master File
Tax-deductibility: IRS Publication 78
| Total |
|---|
| Stephen Del Sesto | Liquidating Receiver | 1 | $0 | $0 | $0 | $0 |
Stephen Del Sesto
Liquidating Receiver
$0
Hrs/Wk
1
Compensation
$0
Related Orgs
$0
Other
$0
| $1M |
| -$2.7M |
| 2019 | $63.5K | $0 | $674K | $11M | $7.2M |
| 2018 | $1.7M | $0 | $1.7M | $11.5M | $7.8M |
| 2017 | $352.5K | $0 | $355K | $11.3M | $7.5M |
| 2016 | $345.7K | $0 | $434.4K | $1.5M | -$2.5M |
| 2015 | $123.2K | $0 | $280.1K | $2.5M | -$2.4M |
| 2014 | $156.7M | $466.7K | $110M | $9.5M | $1.1M |
| 2013 | $174.1M | $5.1M | $175.9M | $100.1M | $42.9M |
| 2012 | $173.8M | $6.2M | $172.2M | $102.8M | $43.4M |
| 2011 | $165.6M | $6.1M | $164M | $94.4M | $38.9M |
| 2021 | 990 | Data |
| 2020 | 990 | Data | PDF not yet published by IRS |
| 2019 | 990 | Data |
| 2018 | 990 | Data |
| 2017 | 990 | Data |
| 2016 | 990 | Data |
| 2015 | 990 | Data |
| 2014 | 990 | Data |
| 2013 | 990 | Data |
| 2012 | 990 | Data |
| 2011 | 990 | Data |
| 2010 | 990 | — |
| 2009 | 990 | — |
| 2008 | 990 | — |
| 2007 | 990 | — |
| 2006 | 990 | — |
| 2005 | 990 | — |
| 2004 | 990 | — |
| 2003 | 990 | — |
| 2002 | 990 | — |
| 2001 | 990 | — |